Skip to content

PCNL Versus RIRS for Management of Stones in Solitary Kidney

Percutaneous Nephrolithotomy Versus Retrograde Intrarenal Surgery for Management of Stones in Solitary Kidney: Assessment of Outcomes and Complications Through a Prospective Non Randomized Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07730892
Enrollment
83
Registered
2026-07-28
Start date
2024-11-23
Completion date
2026-10-01
Last updated
2026-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Stones

Brief summary

Few studies compared PCNL and RIRS for stones in solitary kidney. Current guidelines do not provide clear recommendations concerning the management of renal stones in patients with solitary kidney. The study aims to compare the safety and efficacy of the use of percutaneous nephrolithotomy (PCNL) and flexible ureteroscopy in the treatment of renal stones \_ ≤ 3 cm in largest diameter through a prospective non randomized study in the period between August 2024 and August 2026. Stone-free rate will be assessed by NCCT done at 1st day postoperative and after 3 months. For Evaluation of kidney function postoperatively, creatinine clearance will be done after 1month and renal isotope scan will be done after 3 months. In addition, the results will be compared to the data of the patients with solitary kidney and renal stones who were retrospectively treated by PCNL or RIRS in the period between 2002 and 2024. The cases should fulfil the same inclusion criteria of the prospective study.

Interventions

PROCEDUREretrograde intra renal surgery (RIRS)

standard retrograde intrarenal surgery (RIRS) for management of stones in solitary kidney

PROCEDUREpercutaneous nephrolithotomy (PCNL)

standard percutaneous nephrolithotomy (PCNL) for management of stones in solitary kidney

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with anatomical or functional solitary kidney. * Renal stones ≤ 3 cm in largest diameter- as measured by non-contrast spiral CT * Age ≥ 18 years.

Exclusion criteria

* Patients who did not meet the above criteria. * bleeding diathesis or those on anticoagulant therapy. * concomitant pathology as ureteric stricture or renal congenital anomalies .

Design outcomes

Primary

MeasureTime frameDescription
stone free ratewithin 3 months after surgeryStone-free status: it will be assessed by NCCT (defined as the absence of any stones or presence of only clinically insignificant residual stones \< 4 mm as measured by NCCT). Sub classified to * Initial stone free rate (1st day postoperative) * Final stone free rate (after 3 months)

Secondary

MeasureTime frameDescription
complication ratewithin 30 days after surgeryintra-operative and post operative complications according to clavien- dindo classification
number of sessions3 months after surgerynumber of sessions needed to achieve complete stone clearance
renal function evaluationwithin 3 months after surgeryrenal function assessed by eGFR
auxiliary procedureswithin 3 months after surgeryneed for auxiliary procedures after primary intervention
hospital stayfrom date of surgery until hospital discharge ( up to 30 days )duration of postoperative hospital stay

Countries

Egypt

Contacts

PRINCIPAL_INVESTIGATORAhmed M. Shoma, Professor of urology

Urology and Nephrology Center , Mansoura university , Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 29, 2026